Of all 445 samples, 63.8% of tumor samples were positive for NEDD4 staining, which is similar to a previous report in which NEDD4-positive expression was observed in 55% of BC tumor samples [15] (Fig. 2a). The gene discussed is NEDD4; the disease is neoplasm.